Clinical Trial

Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD

Name: Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD — clinical trial record (NCT07418177)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Phase I Study of the Safety and Preliminary Efficacy of Human induced pluripotent stem cells-derived Retinal Pigment Epithelial (HiPSC-RPE) Cells Subretinal Transplantation in Late-Stage Age-Related Macular Degeneration(AMD) Patients

Trial Details

NCT Number	NCT07418177
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University
Conditions	AMD - Age-Related Macular Degeneration
Enrollment	9 participants
Start Date	2026-02-10
Primary Completion	2028-06-01 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-02-18